Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect-site concentration of remifentanil to blunt endotracheal intubation responses in elderly patients under etomidate anesthesia
ChiCTR2300076261Phase 4Recruiting
- Sponsor
- Peking University Shenzhen Hospital
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remifentanil, sponsored by Peking University Shenzhen Hospital. Primary endpoints: Blood pressure, Heart rate and 2 more. Started Oct 2023; status: recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on ChiCTR2300076261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076261.